Alexander disease (AD), a rare neurodegenerative disorder of the central nervous system, is characterized by the accumulation of cytoplasmic protein aggregates (Rosenthal fibers) composed of glial fibrillary acidic protein (GFAP) and small heat-shock proteins within astrocytes. To date, more than 40 different GFAP mutations have been reported in AD. The present study is aimed at the molecular diagnosis of Italian patients suspected to be affected by AD. By analyzing the GFAP gene of 13 unrelated patients (eight with infantile form, two with juvenile form and three with adult form), we found 11 different alleles, including four new ones. Among the novel mutations, three (p.R70Q, p.R73K, and p.R79P) were identified in exon 1 and p.L359P in exon 6. The sequence analysis also detected six different single nucleotide polymorphic variants, including two previously unreported ones, spread throughout non-coding regions (introns 2, 3, 5, 6, and 3'UTR) of the gene. All patients were heterozygous for the mutations, thus confirming their dominant effect.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0004.2007.00869.xDOI Listing

Publication Analysis

Top Keywords

gfap mutations
8
italian patients
8
alexander disease
8
gfap
4
mutations polymorphisms
4
polymorphisms unrelated
4
unrelated italian
4
patients
4
patients alexander
4
disease alexander
4

Similar Publications

Objective: Physical activity (PA) has been linked to reduced Alzheimer's disease (AD) risk. However, less is known about its effects in the AD preclinical stage. We aimed to investigate whether greater PA was associated with lower plasma biomarkers of AD pathology, neural injury, reactive astrocytes, and better cognition in individuals with autosomal-dominant AD due to the presenilin-1 E280A mutation who are virtually guaranteed to develop dementia.

View Article and Find Full Text PDF

The GC hexanucleotide repeat expansion in C9ORF72 is the major genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9-ALS/FTD). Despite considerable efforts, the development of mouse models of C9-ALS/FTD useful for therapeutic development has proven challenging due to the intricate interplay of genetic and molecular factors underlying this neurodegenerative disorder, in addition to species differences. This study presents a robust investigation of the cellular pathophysiology and behavioral outcomes in a previously described AAV mouse model of C9-ALS expressing 66 GC hexanucleotide repeats.

View Article and Find Full Text PDF

The GC hexanucleotide repeat expansion in the major genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9-ALS/FTD). Despite considerable efforts, the development of mouse models of C9-ALS/FTD useful for therapeutic development has proven challenging due to the intricate interplay of genetic and molecular factors underlying this neurodegenerative disorder, in addition to species differences. This study presents a robust investigation of the cellular pathophysiology and behavioral outcomes in a previously described AAV mouse model of C9-ALS expressing 66 GC hexanucleotide repeats.

View Article and Find Full Text PDF
Article Synopsis
  • Concussions are increasingly recognized as a serious health issue, with the need to better understand minor traumatic brain injuries (mTBI) and their long-term effects like second impact syndrome and chronic traumatic encephalopathy (CTE).
  • Current diagnostic methods for concussions primarily rely on subjective assessments, which can lead to uncertainties in diagnosis despite some assistance from neurocognitive tests.
  • Emerging research is focusing on developing objective diagnostic tools, such as specific biomarkers and advanced imaging techniques, to improve the accuracy of concussion diagnosis and management.
View Article and Find Full Text PDF

Establishment and Use of Primary Cultured Astrocytes from Alexander Disease Model Mice.

Int J Mol Sci

November 2024

Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Chuo 409-3898, Japan.

Alexander disease (AxD) is an intractable neurodegenerative disease caused by mutations in (), which is predominantly expressed in astrocytes. Thus, AxD is a primary astrocyte disease. However, it remains unclear how mutations affect astrocytes and cause AxD pathology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!